Patents by Inventor Caroline Oakley

Caroline Oakley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods using the yeast YMR107W promoter
    Patent number: 7285399
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: October 23, 2007
    Assignee: AstraZeneca AB
    Inventors: Graham P Belfield, Caroline Oakley
  • Compositions and methods using the yeast YMR107W promoter
    Publication number: 20060211118
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Application
    Filed: May 9, 2006
    Publication date: September 21, 2006
    Applicant: AstraZeneca AB
    Inventors: Graham Belfield, Caroline Oakley
  • Compositions and methods utilizing the yeast ZE01 promoter
    Patent number: 7078190
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: July 18, 2006
    Inventors: Graham P Belfield, Caroline Oakley
  • Compositions and methods using the yeast YLR110C promoter
    Patent number: 7067282
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: June 27, 2006
    Assignee: AstraZeneca AB
    Inventors: Graham P Beifield, Caroline Oakley
  • Compositions and methods using the yeast YLR110C promoter
    Publication number: 20060057676
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Application
    Filed: September 30, 2005
    Publication date: March 16, 2006
    Applicant: AstraZeneca AB
    Inventors: Graham Belfield, Caroline Oakley
  • Compositions and methods utilizing the yeast ZE01 promoter
    Publication number: 20040142478
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Application
    Filed: February 12, 2004
    Publication date: July 22, 2004
    Applicant: AstraZeneca AB
    Inventors: Graham P. Belfield, Caroline Oakley
  • Compositions and methods utilizing the yeast ZE01 promoter
    Patent number: 6716601
    Abstract: The invention provides novel yeast promoters useful for controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. The yeast promoters are induced by a fermentable carbon source, such as glucose, or a non-fermentable carbon source, such as ethanol, or both. Therefore, expression of nucleic acid molecules encoding a polypeptide under the control of the novel yeast promoters may be regulated by varying the level of a fermentable carbon source, or a non-fermentable carbon source, or both.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: April 6, 2004
    Assignee: AstraZeneca AB
    Inventors: Graham P Belfield, Caroline Oakley